Theravance Biopharma vs. Peers Comparison - Benzinga

Theravance Biopharma Inc

TBPHNASDAQ

Trade with Public

Trade with Public

$17.03

近くで: Sep 25, 5:00 PM EST

$17.04

0.0140.08%

時間外: Sep 23, 5:58 PM EST

M&A: Theravance Biopharma (TBPH) was acquired by Zymeworks (ZYME) on Wednesday, September 23, 2026 for $929M paid in cash

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Theravance Biopharma vs. Peers Comparison

Compare Theravance Biopharma (TBPH) to its peers on price performance, valuation multiples and key financial metrics.

© 2026 Benzinga | All Rights Reserved